Marex Group plc [MRX] vs Goldman Sachs [GS] Detailed Stock Comparison
Marex Group plc
NASDAQ
Loading...
Goldman Sachs
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Marex Group plc wins in 8 metrics, Goldman Sachs wins in 9 metrics, with 0 ties. Goldman Sachs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Marex Group plc | Goldman Sachs | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.57 | 16.10 | Marex Group plc |
| Price-to-Book Ratio | 2.48 | 1.94 | Goldman Sachs |
| Debt-to-Equity Ratio | 887.54 | 588.39 | Goldman Sachs |
| PEG Ratio | 11.74 | 0.61 | Goldman Sachs |
| EV/EBITDA | 1.94 | N/A | N/A |
| Profit Margin (TTM) | 10.14% | 28.40% | Goldman Sachs |
| Operating Margin (TTM) | 14.55% | 35.74% | Goldman Sachs |
| EBITDA Margin (TTM) | 14.55% | 35.74% | Goldman Sachs |
| Return on Equity | 26.52% | 12.74% | Marex Group plc |
| Return on Assets (TTM) | 1.09% | 0.90% | Marex Group plc |
| Free Cash Flow (TTM) | $1.14B | $-15.30B | Marex Group plc |
| Dividend Yield | 2.01% | 1.42% | Marex Group plc |
| 1-Year Return | 48.60% | 45.63% | Marex Group plc |
| Price-to-Sales Ratio (TTM) | 0.98 | 4.04 | Marex Group plc |
| Enterprise Value | $1.68B | $-24.30B | Marex Group plc |
| EV/Revenue Ratio | 0.64 | -0.44 | Goldman Sachs |
| Gross Profit Margin (TTM) | 38.83% | N/A | N/A |
| Revenue per Share (TTM) | $37 | $171 | Goldman Sachs |
| Earnings per Share (Diluted) | $3.31 | $45.39 | Goldman Sachs |
| Beta (Stock Volatility) | N/A | 1.37 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Marex Group plc vs Goldman Sachs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Marex Group plc | -0.22% | 2.94% | -5.36% | -17.71% | -0.61% | 10.76% |
| Goldman Sachs | 3.62% | 1.53% | 5.92% | 24.01% | 18.49% | 29.03% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Marex Group plc | 48.60% | 89.58% | 89.58% | 89.58% | 89.58% | 89.58% |
| Goldman Sachs | 45.63% | 120.54% | 257.18% | 295.15% | 430.87% | 575.98% |
Performance & Financial Health Analysis: Marex Group plc vs Goldman Sachs
| Metric | MRX | GS |
|---|---|---|
| Market Information | ||
| Market Cap | $2.55B | $221.28B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 1,212,790 | 1,585,930 |
| 90 Day Avg. Volume | 1,201,233 | 1,935,293 |
| Last Close | $36.02 | $741.89 |
| 52 Week Range | $22.33 - $49.34 | $439.38 - $749.05 |
| % from 52W High | -27.00% | -0.96% |
| All-Time High | $49.34 (May 12, 2025) | $749.05 (Aug 15, 2025) |
| % from All-Time High | -27.00% | -0.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.14% |
| Quarterly Earnings Growth | 0.29% | 0.22% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.28% |
| Operating Margin (TTM) | 0.15% | 0.36% |
| Return on Equity (TTM) | 0.27% | 0.13% |
| Debt to Equity (MRQ) | 887.54 | 588.39 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.14 | $376.89 |
| Cash per Share (MRQ) | $148.95 | $3,402.82 |
| Operating Cash Flow (TTM) | $1.64B | $-22,851,999,744 |
| Levered Free Cash Flow (TTM) | $204.70M | $13.53B |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.01% | 1.42% |
| Last 12-Month Dividend | $0.72 | $9.00 |
Valuation & Enterprise Metrics Analysis: Marex Group plc vs Goldman Sachs
| Metric | MRX | GS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.57 | 16.10 |
| Forward P/E | 11.74 | 17.59 |
| PEG Ratio | 11.74 | 0.61 |
| Price to Sales (TTM) | 0.98 | 4.04 |
| Price to Book (MRQ) | 2.48 | 1.94 |
| Market Capitalization | ||
| Market Capitalization | $2.55B | $221.28B |
| Enterprise Value | $1.68B | $-24,295,071,744 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.64 | -0.44 |
| Enterprise to EBITDA | 1.94 | N/A |
| Risk & Other Metrics | ||
| Beta | N/A | 1.37 |
| Book Value per Share (MRQ) | $14.14 | $376.89 |
Financial Statements Comparison: Marex Group plc vs Goldman Sachs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MRX | GS |
|---|---|---|
| Revenue/Sales | $865.70M | $15.06B |
| Cost of Goods Sold | $544.70M | N/A |
| Gross Profit | $321.00M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $239.30M | N/A |
| EBITDA | $247.90M | N/A |
| Pre-Tax Income | $98.00M | $5.65B |
| Income Tax | $25.50M | $909.00M |
| Net Income (Profit) | $72.50M | $4.74B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MRX | GS |
|---|---|---|
| Cash & Equivalents | $2.61B | $167.41B |
| Total Current Assets | $23.78B | N/A |
| Total Current Liabilities | $21.77B | N/A |
| Long-Term Debt | $1.54B | $271.73B |
| Total Shareholders Equity | $1.05B | $124.30B |
| Retained Earnings | $775.30M | $157.02B |
| Property, Plant & Equipment | $86.80M | $24.59B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MRX | GS |
|---|---|---|
| Operating Cash Flow | N/A | $11.67B |
| Capital Expenditures | N/A | $-354.00M |
| Free Cash Flow | N/A | $-37.73B |
| Debt Repayment | N/A | $-17.14B |
| Common Stock Repurchase | N/A | $-4.36B |
Short Interest & Institutional Ownership Analysis
| Metric | MRX | GS |
|---|---|---|
| Shares Short | 3.16M | 5.98M |
| Short Ratio | 2.45 | 2.65 |
| Short % of Float | 0.09% | 0.02% |
| Average Daily Volume (10 Day) | 1,212,790 | 1,585,930 |
| Average Daily Volume (90 Day) | 1,201,233 | 1,935,293 |
| Shares Outstanding | 70.29M | 310.65M |
| Float Shares | 51.28M | 287.06M |
| % Held by Insiders | 0.25% | 0.01% |
| % Held by Institutions | 0.76% | 0.75% |
Dividend Analysis & Yield Comparison: Marex Group plc vs Goldman Sachs
| Metric | MRX | GS |
|---|---|---|
| Last 12-Month Dividend | $0.72 | $9.00 |
| Last 12-Month Dividend Yield | 2.01% | 1.42% |
| 3-Year Avg Annual Dividend | $0.24 | $9.08 |
| 3-Year Avg Dividend Yield | 0.45% | 0.67% |
| 3-Year Total Dividends | $0.72 | $27.25 |
| Ex-Dividend Date | Aug 26, 2025 | Feb 28, 2025 |